UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Cysteine is a limiting factor for glioma proliferation and survival

Molecular oncology, 2022-05, Vol.16 (9), p.1777-1794

2022

Volltextzugriff (PDF)

A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris‐Associated Bacteria

Phytotherapy research, 2017-03, Vol.31 (3), p.410-417

2017

Volltextzugriff (PDF)

Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma

Cancer research (Chicago, Ill.), 2019-10, Vol.79 (19), p.5060-5073

2019

Volltextzugriff (PDF)

IDH1 mutations induce organelle defects via dysregulated phospholipids

Nature communications, 2021-01, Vol.12 (1), p.614-16, Article 614

2021

Volltextzugriff (PDF)

Urinary Metabolic Distinction of Niemann–Pick Class 1 Disease through the Use of Subgroup Discovery

Metabolites, 2023-10, Vol.13 (10), p.1079

2023

Volltextzugriff (PDF)

Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model

Frontiers in oncology, 2022-10, Vol.12, p.979537-979537

2022

Volltextzugriff (PDF)

Gut microbiome and metabolome in a non-human primate model of chronic excessive alcohol drinking

Translational psychiatry, 2021-12, Vol.11 (1), p.609-609, Article 609

2021

Volltextzugriff (PDF)

NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls

Scientific reports, 2017-07, Vol.7 (1), p.6320-12, Article 6320

2017

Volltextzugriff (PDF)

Metabolic Landscape of a Genetically Engineered Mouse Model of IDH1 Mutant Glioma

Cancers, 2020-06, Vol.12 (6), p.1633

2020

Volltextzugriff (PDF)

Sphingolipid Pathway as a Source of Vulnerability in IDH1mut Glioma

Cancers, 2020-10, Vol.12 (10), p.2910

2020

Volltextzugriff (PDF)

Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism

Proceedings of the National Academy of Sciences - PNAS, 2020-05, Vol.117 (18), p.9964-9972

2020

Volltextzugriff (PDF)

Metabolic plasticity of IDH1 -mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibition

Cancer & metabolism, 2020-10, Vol.8 (1), p.23-23, Article 23

2020

Volltextzugriff (PDF)

DDRE-01. METABOLIC PLASTICITY AND HETEROGENEITY IN IDH1MUT CELL LINES PRODUCES RESISTANCE TO GLUTAMINASE INHIBITION BY CB839

Neuro-oncology advances, 2021-03, Vol.3 (Supplement_1), p.i6-i6

2021

Volltextzugriff (PDF)

Magnetic resonance spectroscopy for the study of cns malignancies

Progress in nuclear magnetic resonance spectroscopy, 2021-02, Vol.122, p.23-41

2021

Volltextzugriff (PDF)

DDRE-19. SPHINGOSINE KINASE 1 AS A THERAPEUTIC TARGET FOR IDH1-R132H mut GLIOMA

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi78-vi78

2021

Volltextzugriff (PDF)

Abstract 2508: Profiling the metabolic effects of AGI-5198 treatment on IDH1-mutated gliomas

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2508-2508

2017

Volltextzugriff (PDF)

Methylphenidate alters monoaminergic and metabolic pathways in the cerebellum of adolescent rats

European neuropsychopharmacology, 2018-04, Vol.28 (4), p.513-528

2018

Volltextzugriff (PDF)

CBMT-44. METABOLIC PLASTICITY AND HETEROGENEITY IN IDH1MUT CELL LINES PRODUCES RESISTANCE TO GLUTAMINASE INHIBITION BY CB839

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi42-vi42

2018

Volltextzugriff (PDF)

1H NMR-based metabolomics reveals neurochemical alterations in the brain of adolescent rats following acute methylphenidate administration

Neurochemistry international, 2017-09, Vol.108, p.109-120

2017

Volltextzugriff (PDF)

A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria: Antimicrobial Topical Preparations for Acne Vulgaris

Phytotherapy research, 2017-03, Vol.31 (3), p.410-417

2017

Volltextzugriff (PDF)

Sphingolipid Pathway as a Source of Vulnerability in IDH1 mut Glioma

Cancers, 2020-10, Vol.12 (10)

2020

Volltextzugriff (PDF)

Sphingolipid Pathway as a Source of Vulnerability in [IDH1.sup.] Glioma

Cancers, 2020-10, Vol.12 (10), p.1

2020

Volltextzugriff (PDF)

METB-04. METABOLIC EFFECTS OF A GLUTAMINASE INHIBITOR ON GLIOMA CELL LINES

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi129-vi129

2017

Volltextzugriff (PDF)

BIMG-10. IDH1 MUTATIONS INDUCE ORGANELLE DEFECTS VIA DYSREGULATED PHOSPHOLIPIDS

Neuro-oncology advances, 2021-03, Vol.3 (Supplement_1), p.i3-i3

2021

Volltextzugriff (PDF)

DDRE-20. TARGETING SPHINGOLIPID PATHWAY REVEALS VULNERABILITY IN IDH1MUT GLIOMA

Neuro-oncology advances, 2021-03, Vol.3 (Suppl 1), p.i10-i10

2021

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(40)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cysteine is a limiting factor for glioma proliferation and survival

A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris‐Associated Bacteria

Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma

IDH1 mutations induce organelle defects via dysregulated phospholipids

Urinary Metabolic Distinction of Niemann–Pick Class 1 Disease through the Use of Subgroup Discovery

Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model

Gut microbiome and metabolome in a non-human primate model of chronic excessive alcohol drinking

NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls

Metabolic Landscape of a Genetically Engineered Mouse Model of IDH1 Mutant Glioma

Sphingolipid Pathway as a Source of Vulnerability in IDH1mut Glioma

Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism

Metabolic plasticity of IDH1 -mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibition

DDRE-01. METABOLIC PLASTICITY AND HETEROGENEITY IN IDH1MUT CELL LINES PRODUCES RESISTANCE TO GLUTAMINASE INHIBITION BY CB839

Magnetic resonance spectroscopy for the study of cns malignancies

DDRE-19. SPHINGOSINE KINASE 1 AS A THERAPEUTIC TARGET FOR IDH1-R132H mut GLIOMA

Abstract 2508: Profiling the metabolic effects of AGI-5198 treatment on IDH1-mutated gliomas

Methylphenidate alters monoaminergic and metabolic pathways in the cerebellum of adolescent rats

CBMT-44. METABOLIC PLASTICITY AND HETEROGENEITY IN IDH1MUT CELL LINES PRODUCES RESISTANCE TO GLUTAMINASE INHIBITION BY CB839

1H NMR-based metabolomics reveals neurochemical alterations in the brain of adolescent rats following acute methylphenidate administration

A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria: Antimicrobial Topical Preparations for Acne Vulgaris

Sphingolipid Pathway as a Source of Vulnerability in IDH1 mut Glioma

Sphingolipid Pathway as a Source of Vulnerability in [IDH1.sup.] Glioma

METB-04. METABOLIC EFFECTS OF A GLUTAMINASE INHIBITOR ON GLIOMA CELL LINES

BIMG-10. IDH1 MUTATIONS INDUCE ORGANELLE DEFECTS VIA DYSREGULATED PHOSPHOLIPIDS

DDRE-20. TARGETING SPHINGOLIPID PATHWAY REVEALS VULNERABILITY IN IDH1MUT GLIOMA

Suchergebnisse filtern